Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma.

Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma.

Int J Mol Sci. 2017 Aug 31;18(9):

Authors: Hoffman RM

Abstract
Metastatic melanoma is a recalcitrant tumor. Although "targeted" and immune therapies have been highly touted, only relatively few patients have had durable responses. To overcome this problem, our laboratory has established the melanoma patient-derived orthotopic xenograft (PDOX) model with the use of surgical orthotopic implantation (SOI). Promising results have been obtained with regard to identifying effective approved agents and experimental therapeutics, as well as combinations of the two using the melanoma PDOX model.

PMID: 28858204 [PubMed - in process]

http://ift.tt/2vx7qDA